We analyzed the correlation of ITGA8 and tumor mutational burden (TMB), neoantigen, and tumor heterogeneity to further explore the relationship between ITGA8 and immune microenvironment and immunotherapy. This evidence concerns the gene ITGA8 and neoplasm.